First Trust Exchange Traded Fund Nyse Arca Biotechnology Index Fund Newsroom

Argenx Analyst Ratings

BenzingaJul 23 10:43 ET

Oppenheimer Upgrades Argenx SE to Outperform From Perform, $546 Price Target

MT NewswiresJul 23 08:58 ET

Gilead Sciences (GILD) Receives a Buy From TD Cowen

TipRanksJul 23 07:46 ET

Oppenheimer Upgrades Argenx SE(ARGX.US) to Buy Rating, Announces Target Price $546

Moomoo NewsJul 23 07:42 ET

TD Cowen Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $85

Moomoo NewsJul 23 07:33 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (IQV), Vertex Pharmaceuticals (VRTX) and Gilead Sciences (GILD)

TipRanksJul 23 05:03 ET

Gilead Sciences: A Balanced Outlook With Steady HIV Performance and Oncology Challenges Justifying a Hold Rating

TipRanksJul 23 05:03 ET

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Jasper Therapeutics (JSPR)

TipRanksJul 22 20:33 ET

Gilead Sciences Analyst Ratings

BenzingaJul 22 11:27 ET

Argenx Price Target Maintained With a $519.00/Share by Wedbush

Dow JonesJul 22 09:43 ET

Halozyme Therapeutics Analyst Ratings

BenzingaJul 22 09:35 ET

Argenx Analyst Ratings

BenzingaJul 22 09:33 ET

Cantor Fitzgerald Adjusts Price Target on Gilead Sciences to $70 From $75

MT NewswiresJul 22 09:27 ET

Wedbush Sticks to Its Buy Rating for Argenx Se (ARGX)

TipRanksJul 22 07:47 ET

Truist Financial Reaffirms Their Buy Rating on Argenx Se (ARGX)

TipRanksJul 22 07:12 ET

Truist Securities Adjusts Price Target on Argenx to $540 From $480, Maintains Buy Rating

MT NewswiresJul 22 05:33 ET

Jefferies Sticks to Their Buy Rating for Gilead Sciences (GILD)

TipRanksJul 19 08:17 ET

Genmab Analyst Ratings

BenzingaJul 18 08:37 ET

TD Cowen Keeps Their Hold Rating on Genmab (GMAB)

TipRanksJul 18 07:39 ET

Wells Fargo Sticks to Its Buy Rating for United Therapeutics (UTHR)

TipRanksJul 18 06:22 ET